Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin)

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 4, 1998, Pages 945-946

  Barry, A L ^a   Fuchs, P C ^a   Brown, S D ^a  

^a CLINICAL MICROBIOLOGY INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CLINDAMYCIN; DALFOPRISTIN; ERYTHROMYCIN; LINCOSAMIDE; MACROLIDE; QUINUPRISTIN; STREPTOGRAMIN; TELITHROMYCIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; CROSS RESISTANCE; DRUG EFFICACY; GENE TARGETING; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; NOTE; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TARGET CELL;

EID: 0031968046     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.4.945     Document Type: Note

References (11)

1. Barry, A. L., P. C. Fuchs, and S. D. Brown. 1997. Macrolide resistance among Streptococcus pneumoniae and Streptococcus pyogenes isolates from outpatients in the USA. J. Antimicrob. Chemother. 40:139-140.
2. Barry, A. L., M. A. Pfaller, P. C. Fuchs, and R. R. Packer. 1994. In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory tract pathogens from U.S. medical centers in 1992 and 1993. Antimicrob. Agents Chemother. 38:2419-2425.
3. Biedenbach, D., A. Wanger, and R. N. Jones. 1996. Comparative in vitro activity of quinupristin/dalfopristin (RP 59500) tested against penicillin- and macrolide-resistant pneumococci by the E test. J. Antimicrob. Chemother. 38:553-555.
4. Doern, G. V., A. Brueggemann, H. P. Holley, Jr., and A. M. Rauch. 1996. Antimicrobial resistance of Streptococcus pneumoniae recovered from out-patients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob. Agents Chemother. 40:1208-1213.
5. Fasola, E. L., S. Bajaksouzian, P. C. Appelbaum, and M. R. Jacobs. 1997. Variation in erythromycin and clindamycin susceptibilities of Streptococcus pneumoniae by four test methods. Antimicrob. Agents Chemother. 41:129-134.
6. Jones, R. N., and D. J. Biedenbach. 1997. Antimicrobial activity of RU-66647, a new ketolide. Diagn. Microbiol. Infect. Dis. 27:7-12.
7. Jones, R. N., M. G. Cormican, and A. Wanger. 1996. Clindamycin resistance among erythromycin-resistant Streptococcus pneumoniae. Diagn. Microbiol. Infect. Dis. 25:201-204.
8. Leclercq, R., and P. Courvalin. 1993. Resistance to macrolides, azalides and streptogramins, p. 33-40. In H. C. Neu, S. S. Young, and S. H. Zinner (ed.), The new macrolides, azalides, and streptogramins: pharmacology and clinical applications. Marcel Dekker, Inc., New York, N.Y.
9. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Wayne, Pa.
10. Shortridge, V. D., R. K. Flamm, N. Ramer, J. Beyer, and S. K. Tanaka. 1996. Novel mechanism of macrolide resistance in Streptococcus pneumoniae. Diagn. Microbiol. Infect. Dis. 26:73-78.
11. Sutcliffe, J., A. Tait-Kamradt, and L. Wondrack. 1996. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother. 40:1817-1824.